The wire-free AID strategy identified a cause of myocardial ischemia in 84.3% of patients, doubling the identification rate compared to coronary angiography alone (P < 0.0001).
Does a wire-free advanced invasive diagnosis strategy improve the identification of the cause of myocardial ischemia in patients with chronic coronary syndrome compared with coronary angiography alone?
A wire-free advanced invasive diagnostic strategy significantly improves the identification of myocardial ischemia causes in chronic coronary syndrome compared to angiography alone, while showing high agreement with traditional wire-based methods.
Absolute Event Rate: 0% vs 0%
BACKGROUND: Current clinical guidelines recommend considering both obstructive and nonobstructive causes of myocardial ischemia in patients with chronic coronary syndrome. Wire-based physiological assessment constitutes a valid approach for this purpose, but it remains underutilized. We evaluated the diagnostic yield and clinical impact of an alternative wire-free approach for this purpose. METHODS: This is a subanalysis of the multicenter, prospective AID-ANGIO study (Advanced Invasive Diagnosis for Patients with Chronic Coronary Syndromes Undergoing Coronary Angiography), evaluating the impact of a wire-free advanced invasive diagnosis (AID) strategy in the diagnostic workflow of patients with chronic coronary syndrome admitted to the catheterization laboratory. The wire-free AID strategy combined quantitative flow ratio for epicardial evaluation, contrast angiography-derived index of coronary microcirculatory resistance for microvascular assessment, and acetylcholine testing for the endothelial-dependent coronary function. RESULTS: The study included 262 patients. The wire-free AID strategy identified a cause of myocardial ischemia in 84.3% of patients, representing a 2-fold increase in the identification of a cause of myocardial ischemia, compared with coronary angiography alone ( P <0.0001). In addition, the wire-free AID strategy demonstrated substantial agreement compared with the wire-based AID strategy (Cohen κ 0.78). The wire-free AID strategy led to a change in the initial therapeutic plan in 55.3% of patients compared with coronary angiography. Nevertheless, the wire-free AID strategy maintained good concordance with the wire-based AID strategy (16.8% of therapeutic changes). CONCLUSIONS: This study supports the clinical utility of a wire-free AID strategy in patients with chronic coronary syndrome, demonstrating its potential to improve diagnostic yield and guide clinical decision-making compared with coronary angiography alone. In addition, it shows substantial agreement with the wire-based approach.
Lombardi et al. (Fri,) reported a other. The wire-free AID strategy identified a cause of myocardial ischemia in 84.3% of patients, doubling the identification rate compared to coronary angiography alone (P < 0.0001).